Chlamydia pneumoniae in atherosclerotic middle cerebral artery
- PMID: 11546883
- DOI: 10.1161/hs0901.094290
Chlamydia pneumoniae in atherosclerotic middle cerebral artery
Abstract
Background and purpose: Atherosclerotic middle cerebral arteries are frequent sites of thrombosis, leading to stroke. Previous studies have suggested a role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis. However, the presence of this pathogen in atherosclerotic middle cerebral arteries has heretofore not been documented. In the present study, we analyzed atheromatous plaques from middle cerebral arteries for the presence of C pneumoniae.
Methods: Atherosclerotic middle cerebral arteries from 15 cadavers who died of natural causes and corresponding nonatherosclerotic arteries from 4 otherwise healthy trauma victims were examined. Assays for C pneumoniae DNA were carried out by nested polymerase chain reaction (nPCR) specific for the C pneumoniae ompA gene. The presence of the bacterium was assessed by transmission electron microscopy.
Results: Five of the 15 atherosclerotic arterial samples and none of the control tissues were positive for C pneumoniae by nPCR. Particles similar in morphology and size to C pneumoniae elementary bodies were detected by transmission electron microscopy in 4 of the 5 nPCR-positive atherosclerotic samples.
Conclusions: The demonstration of C pneumoniae in atherosclerotic middle cerebral arteries is consistent with the hypothesis that this bacterium is involved in acute and chronic cerebrovascular diseases.
Similar articles
-
Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.Stroke. 2002 Dec;33(12):2756-61. doi: 10.1161/01.str.0000039322.66575.77. Stroke. 2002. PMID: 12468766 Clinical Trial.
-
Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis.Pathol Int. 2002 Dec;52(12):755-63. doi: 10.1046/j.1440-1827.2002.01422.x. Pathol Int. 2002. PMID: 12588444
-
Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction.Ann Vasc Surg. 1999 Jul;13(4):421-5. doi: 10.1007/s100169900277. Ann Vasc Surg. 1999. PMID: 10398739
-
Chlamydia pneumoniae in atherosclerotic tissue.J Infect Dis. 2000 Jun;181 Suppl 3:S437-40. doi: 10.1086/315614. J Infect Dis. 2000. PMID: 10839732 Review.
-
Chlamydia pneumoniae in vascular tissue.Atherosclerosis. 1998 Oct;140 Suppl 1:S21-4. doi: 10.1016/s0021-9150(98)00116-6. Atherosclerosis. 1998. PMID: 9859921 Review.
Cited by
-
Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study.BMC Neurol. 2004 Oct 12;4(1):15. doi: 10.1186/1471-2377-4-15. BMC Neurol. 2004. PMID: 15476562 Free PMC article.
-
Infectious burden: a new risk factor and treatment target for atherosclerosis.Infect Disord Drug Targets. 2010 Apr;10(2):84-90. doi: 10.2174/187152610790963519. Infect Disord Drug Targets. 2010. PMID: 20166973 Free PMC article. Review.
-
Limited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis.Open Neurol J. 2008;2:39-44. doi: 10.2174/1874205X00802010039. Epub 2008 Jul 25. Open Neurol J. 2008. PMID: 19018307 Free PMC article.
-
Inflammatory mechanisms of stroke.Stroke. 2010 Oct;41(10 Suppl):S3-8. doi: 10.1161/STROKEAHA.110.594945. Stroke. 2010. PMID: 20876499 Free PMC article. Review.
-
Chlamydia pneumoniae and Cardiovascular Disease.Curr Infect Dis Rep. 2002 Feb;4(1):35-43. doi: 10.1007/s11908-002-0065-4. Curr Infect Dis Rep. 2002. PMID: 11853655
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources